Sunday, September 20, 2026

Aspen Group Soars 16%: Is This Just The Beginning?

ViaNews Editorial Team

September 19, 2023

Aspen Group Soars 16%: Is This Just The Beginning?

(VIANEWS) - Aspen Group (ASPU) Shares Gain 16.73% to EUR0.15 and Extend Yesterday's Uptrend Aspen Group (NASDAQ: ASPU) shares experienced an extraordinary surge on Tuesday, rising 16.73% to EUR0.15 as of 13:35 EST, following its previous session's upward trend. Meanwhile, the wider market as measured by NASDAQ has dropped 0.6% since 13:00 EST to EUR13,628.65; thus indicating bearish trading conditions thus far. Aspen Group closed at EUR0.13, which represents an 85.56% decline from its 52-week high of EUR0.89. Recent performance for Aspen has been marked by fluctuation and its failure to retain momentum amidst market fluctuations.

About Aspen Group

Aspen Group, Inc. is an education technology company providing online degree programs through Aspen University and United States University. They offer higher education services in nursing and health sciences, business technology, arts & sciences and education fields; with 13,334 degree-seekers currently enrolled as of April 30th 2022. Established in 1987 and headquartered in New York City.

Yearly Analysis

Based on available information, Aspen Group (AGPH.DE) stock is currently trading at EUR0.15, significantly lower than its 52-week high of EUR0.89 but higher than its 52-week low of EUR0.03 over the past year. This indicates a dramatic decrease in value over this timeframe. Aspen Group is projected to experience negative sales growth of 16.4% this year and 16.2% for next year - meaning their revenue should decrease over this timeframe. Note that these figures are estimates and subject to change based on market conditions, company performance and economic trends. Investors should conduct additional research before making investment decisions.

Technical Analysis

Aspen Group's stock price has been struggling to maintain momentum as it currently trades below its 50-day and 200-day moving averages of EUR0.15 and EUR0.19 respectively - two indicators that this stock may have experienced an ongoing downward trend in recent times. According to Aspen Group's last reported volume of 34,436 shares is 0.3% higher than its average volume of 34,330 shares and could signal some increased interest for their stock but remains below its average trading volume of 34,330 shares. Looking at Aspen Group's volatility levels over recent weeks and months, investors should be concerned. Intraday variation average for last week, month, and quarter stands at 4.97%, 0.64% and 5.74% respectively - these numbers correspond with its highest amplitude average volatility being 5.91% during last week, 6.52% last month, and 5.74% during quarter. Such high levels could threaten price stability of Aspen Group shares for investors.

Quarter Analysis

As indicated by the data presented here, Aspen Group's current sales growth stands at negative 24% for the current quarter and negative 29.3% for its anticipated next quarter - signalling a substantial decrease in revenue for both periods and raising cause for alarm among investors. Year-on-year quarterly revenue growth has also declined by 17.8% over the last twelve trailing months, reaching 70.92M as of September 2018. This revenue figure indicates that there may be difficulties increasing revenue for this company. Given this information, investors may wish to exercise extreme caution when making any investment decisions regarding Aspen Group. It would also be advisable for them to conduct additional research into the reasons for Aspen Group's decrease in sales and revenue (whether that's market conditions changing or company specific issues) so as to fully comprehend any associated risks and opportunities when investing in its stock.

Equity Analysis

According to available data, Aspen Group currently has a trailing twelve month EPS of EUR-0.39. This indicates that its shareholders are currently not seeing positive earnings growth. Furthermore, its return on equity (ROE) for these twelve trailing months stands at -24.26% indicating inefficient use of shareholder's funds to create profits for Aspen Group shareholders. Investors should proceed with caution when investing in companies with negative earnings and ROE figures, or companies which have experienced recent earnings declines and ROE declines. Waiting for positive trends to develop may be prudent before making a final investment decision, although past performance cannot always predict future success and other factors could potentially impede profitability in the future. It is wise to conduct additional research before making any definitive investments decisions.

More news about Aspen Group (ASPU).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Boom Hits a Fork: Slowdown Calls Clash with Capex Confidence as Markets Get Nervous
Dario Amodei's repeated calls for a global slowdown in frontier AI development, echoed by Microsoft's new humanist AI code of conduct and FTC antitrust caution, are being publicly rejected by Nvidia and Meta leadership even as hyperscaler spending draws fresh skeptical scrutiny (Wachter's analysis, Burry-style overbuilding worries) and weak guidance from Adobe and a post-slowdown-comment selloff in GE Vernova signal investor jitters. Meanwhile wealth and security effects of the AI race keep compounding — Zhang Yiming's fortune surging on AI-driven ByteDance value, a Chinese hacking firm weaponizing AI against stolen government secrets, and low-quality AI-generated products (an AI sitcom, a spam-flooding agent platform) fueling backlash even as adoption races ahead.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,982
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,982 facts checked against source5,299 source documents archived
Query this data → isubstrate.com